SLR FY25 chemistry analyzer/testing mach

Active Definitive Contract Awarded Last action

Contract number
W91YTZ25C0003
Awardee
Awarding agency
Obligated
$1,183,865

Award facts

Opportunity
Contract value 34% obligated
  • $2,074,016.60 Current, with exercised options
  • $3,484,813.26 Potential, with all options
Completion date 39% complete
  • Current, with exercised options
  • Potential, with all options
Contracting staff
Funding agency
Defense Health Agency Department of Defense
Set-aside
No set-aside
Competition
Full and Open Competition · 5 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Columbia, SC 29207, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00006 $0
Supplemental Agreement for work within scope P00005 $130,854
Funding Only Action P00004 · Chemistry/immunochemistry analyzers, reagents and supplies $389,791
Exercise an Option P00002 $0
Supplemental Agreement for work within scope P00001 · SLR bmod FY25 within scope mahc abbott $184,058
Original award $389,791

About this award

The Defense Health Agency awarded a $3.48 million definitive contract to Abbott Laboratories Inc., Abbott Diagnostics Division, for chemistry and immunochemistry analyzers, reagents, and supplies on November 1, 2024, on a firm fixed-price basis with no set-aside.

Place of performance is Columbia, SC. The originating solicitation, posted May 17, 2024, sought equipment and reagents for chemistry testing at the Moncrief Army Health Clinic, including two analyzers, calibration and control materials, disposables, accessories, on-site training, and technical support on a cost-per-reportable-result basis. Requirements specified fully-automated testing capability, Hepatitis A and B testing within 30 minutes, and throughput up to 1,200 patient samples per hour. The contract ceiling is $3.48 million with an ultimate completion date of October 31, 2029. NAICS code 325413 applies (In-Vitro Diagnostic Substance Manufacturing).

Quick answers

Who was awarded contract W91YTZ25C0003?

W91YTZ25C0003 was awarded to Abbott Laboratories Inc. by Medical Command (Department of the Army) on November 1, 2024.

How much is contract W91YTZ25C0003 worth?

The government has obligated $1,183,865 on W91YTZ25C0003. Its current value, with exercised options, is $2,074,017. Its potential value, with all options, is $3,484,813.

Which agency awarded contract W91YTZ25C0003?

Medical Command (Department of the Army) awarded W91YTZ25C0003, with funding from Defense Health Agency (Department of Defense).

Was contract W91YTZ25C0003 competed?

The extent of competition for W91YTZ25C0003 was full and open competition. The government received 5 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award